Henn Matthew R
Reporting owner on Forms 3, 4 and 5, CIK 1767321.
Henn Matthew R reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-11-17.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| MCRB · Seres Therapeutics, Inc.CIK 1609809 | officer (See Remarks) | 1 | 2026-11-17 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| MCRB · Seres Therapeutics, Inc.Common Stock | 2026-11-16 | S sold | -101 | $1.38 | 8,132 | Form 4 |
| MCRB · Seres Therapeutics, Inc.Common Stock | 2026-11-15 | M exercised | +238 | 8,233 | Form 4 | |
| MCRB · Seres Therapeutics, Inc.Restricted Stock Units, derivative | 2026-11-15 | M exercised | -141 | $0 | 141 | Form 4 |
| MCRB · Seres Therapeutics, Inc.Restricted Stock Units, derivative | 2026-11-15 | M exercised | -97 | $0 | 488 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001193125-26-465536 | Seres Therapeutics, Inc. | 2026-11-17 |